Title: Increase in Semaglutide-Related Poison Control Calls Sparks Concern
Subtitle: Patients urged to be cautious with diabetes and weight-loss medication
Jala News – Poison control centers across the United States have reported a sharp rise in calls regarding semaglutide, a medication commonly used to treat diabetes and aid weight loss. Numerous patients have exhibited symptoms of accidental overdoses, including severe nausea, vomiting, and stomach pain.
According to data gathered from January to November, the number of poison center calls related to semaglutide has skyrocketed to nearly 3,000. This represents a staggering 15-fold increase since 2019, raising significant concerns among healthcare professionals and regulators.
The main cause for concern appears to be dosing errors, with the majority of calls involving incidents such as accidental double doses or taking the wrong amount. Compounded versions of semaglutide, which can vary from the patented drug, may require different dosages and are associated with a higher risk of errors.
In response to these issues, the Food and Drug Administration (FDA) has issued warnings against the consumption of compounded versions of the medication. The FDA has also sent warning letters to online sellers of semaglutide, emphasizing the potential dangers associated with these non-standard versions.
While it is unclear whether the reported symptoms stem from the patented drugs or the compounded versions, some believe the latter could be linked to many of the calls. To address these alarming reports, individuals who suspect an overdose or experience symptoms related to semaglutide are advised to immediately contact their local poison control center or call the national hotline at 800-222-1222 for prompt guidance and potential medical attention.
Semaglutide’s manufacturer, Novo Nordisk, has placed patient safety as its top priority. The company states that it is taking necessary steps to ensure the responsible use of their products, acknowledging the seriousness of the situation.
Unfortunately, there is currently no specific antidote available for semaglutide overdose. Medical professionals can provide support by administering intravenous fluids and anti-nausea drugs to help patients as the drug gradually leaves their system. Signs of an overdose may include dizziness, sweating, fatigue, nausea and vomiting, seizures, confusion, and loss of consciousness.
Patients prescribed semaglutide are also being advised to remain vigilant for signs of low blood sugar and the potential dangers of hypoglycemia when combining the medication with other diabetes treatments. Raising awareness about potential risks can help patients better manage their treatment and avoid potential complications.
As the number of semaglutide-related poison control calls continues to surge, healthcare professionals are urging patients to exercise caution when taking the medication. Staying well-informed, following proper dosing instructions, and promptly seeking medical advice in the event of any concerns or symptoms is crucial to ensuring safe and effective treatment.
“Social media scholar. Reader. Zombieaholic. Hardcore music maven. Web fanatic. Coffee practitioner. Explorer.”